Zeynep Eroglu

Zeynep Eroglu at Moffitt Cancer Center is an expert in adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) for melanoma. She has been a principal investigator in trials of lifileucel (the first FDA-approved TIL therapy) and has contributed to advancing TIL therapy through biomarker identification and combination strategies. Her work represents a critical bridge between the fundamental TIL work of Rosenberg's group and clinical adoption.